From sample to insight: how spatial biology is transforming cancer prognosis and clinical research

Spatial biology is moving from research curiosity to clinical reality – and the results are already changing how we understand and treat disease. The key to unlocking its full potential lies in automated, reproducible, end-to-end workflows that turn tissue complexity into clear, actionable decisions.

Key Learnings:

1. Spatial biology has matured into clinical reality

• It has moved from a research curiosity to an operational, clinically impactful platform (e.g. TissueCypher for Barrett’s oesophagus risk stratification).
• Recognition by Nature Methods and the World Economic Forum reflects both scientific and translational relevance.
• Understanding where biomarkers are in tissue and how cell populations interact is critical for prognosis, therapy response and patient stratification.

2. Clinical and commercial proofs now exist

• Castle Biosciences’ TissueCypher: >39,000 test reports in 2025, demonstrating clinical demand and operational maturity for spatially based prognostics.
• Concept Life Sciences: multi-site reproducibility study with coefficients of variation well below the 20% acceptance threshold, showing that standardized workflows can meet regulatory-grade requirements.

3. Spatial biology is strategically relevant beyond diagnostics

• It supports target validation, mechanism-of-action studies, pharmacodynamics, toxicology, trial enrichment and companion diagnostics.
• CROs are building full-service offerings around standardized ZEISS workflows, enabling sponsors without in-house expertise to access spatial biology at scale.

4. Barrier to entry is lowering; strategic adoption is the next step

• With integrated, automated workflows, deep microscopy or spatial biology expertise is no longer a prerequisite to generate high-quality multiplex data.
• The focus for pharma, biotech and CROs should shift from “can we do spatial biology?” to “how do we embed these capabilities into our R&D and clinical strategies?”